Ngā hua rapu kaituhi :: APM

1

Current and future treatment options for polycythemia vera mā Martin Grießhammer, Heinz Gisslinger, Ruben A. Mesa

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Erythropoietin Treatment of Anemia Associated with Multiple Myeloma mā Heinz Ludwig, E. Fritz, H. Kotzmann, P Höcker, Heinz Gisslinger, Ursula Barnas

I whakaputaina 1990

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification mā Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, Veronika Buxhofer‐Ausch, Bettina Gisslinger, Heinz Gisslinger

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera mā Raffaele Landolfi, Roberto Marchioli, Jack Kutti, Heinz Gisslinger, Gianni Tognoni, Carlo Patrono, Tiziano Barbui

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Anagrelide for thrombocytosis in myeloproliferative disorders mā Michael Steurer, Guenther Gastl, Wieslaw‐Wiktor Jedrzejczak, Robert Pytlík, Werner Lin, Ernst Schlögl, Heinz Gisslinger

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha mā Heinz Gisslinger, Bettina Gilly, W. Woloszczuk, Wolfgang R. Mayr, L Havelec, Werner Linkesch, M Weissel

I whakaputaina 1992

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment mā Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Jean‐Jacques Kiladjian, Heinz Gisslinger, Jean‐Jacques Kiladjian

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
8

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial mā Heinz Gisslinger, Mirjana Gotić, Jerzy Hołowiecki, Miroslav Penka, Jüergen Thiele, Hans Michael Kvasnicka, Róbert Královics, Petro E. Petrides

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion mā Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M. Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans mā Aleksandra E. Kornienko, Christoph Dotter, Philipp Guenzl, Heinz Gisslinger, Bettina Gisslinger, Ciara Cleary, Róbert Královics, Florian M. Pauler, Denise P. Barlow

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia mā Marco Ruggeri, Heinz Gisslinger, Alberto Tosetto, C. Rintelen, Christine Mannhalter, Ingrid Pabinger, Navide Heis, Giancarlo Castaman, Edoardo Missiaglia, Klaus Lechner, Francesco Rodeghiero

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F mā Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, André Tichelli, Heinz Gisslinger, Róbert Královics, Radek C. Skoda

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma mā H. Ludwig, Zdeněk Adam, E Tóthová, Roman Hájek, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Johannes Drach, Ingrid Kühn, Axel Hinke, N. Zojer

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders mā Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Róbert Královics, Laura Cremonesi, Radek C. Skoda, Mario Cazzola

I whakaputaina 2007

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma mā Heinz Ludwig, Roman Hájek, Elena Tóthová, Johannes Drach, Zdeněk Adam, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Richard Greil, Ingrid Kühn, Niklas Zojer, Axel Hinke

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study mā Markus S. Anker, Maria Klara Frey, Georg Goliasch, Philipp E. Bartko, Suriya Prausmüller, Heinz Gisslinger, Gabriela Kornek, Guido Strunk, Markus Raderer, Christoph Zielinski, Martin Hülsmann, Noémi Pávó

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study mā Heinz Ludwig, Zdeněk Adam, Roman Hájek, Richard Greil, Elena Tóthová, Felix Keil, Eva Maria Autzinger, Josef Thaler, Heinz Gisslinger, Alois Lang, Miklós Egyed, Irene Womastek, Niklas Zojer

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis mā Alessandro M. Vannucchi, Peter te Boekhorst, Claire Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer‐Perrard, Minghui Duan, Nathalie Francillard, Betty Molloy, Monika Wroclawska, Heinz Gisslinger

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b mā Jean‐Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Heinz Gisslinger, Jean‐Jacques Kiladjian, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Heinz Gisslinger

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
20

Masked polycythemia vera diagnosed according to WHO and BCSH classification mā Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Heinz Gisslinger, Guido Finazzi, Elisa Rumi, Maria Luigia Randi, Alessandro M. Vannucchi, Bettina Gisslinger, Leonhard Müllauer, Marco Ruggeri, Alessandro Rambaldi, Ayalew Tefferi

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: